Indeed, recent experimental evidence indicates that genomic instability triggers immunogenicity [87] of cancer cells by different mechanisms: (1) neo-antigen generation [88], (2) cGAS-STING pathway activation [89], and (3) immunological cell death induction [90]. Here, STING1 is linked to cancer.